(Dr.) Amit Kumar Tiwari

Prof. (Dr.) Amit Kumar Tiwari

orcid
Indian Patent & Design Agent and Senior Patent Associate - C...

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Journal of Energy Storage
Verified
Journal Article
Closed access
BGBabaji Ghule
Babaji Ghule
MLMeena Laad
Meena Laad
(Dr.) Amit Kumar Tiwari(Dr.) Amit Kumar Tiwari
(Dr.) Amit Kumar Tiwari

1 January 2021 in Cancer Treatment and Research Communications
Verified
Journal Article
Open access
PPPrem N. Pandey
Prem N. Pandey
NSNeha Saini
Neha Saini
NSNidhi Sapre
Nidhi Sapre
AKAtul Kulkarni
Atul Kulkarni
(Dr.) Amit Kumar Tiwari(Dr.) Amit Kumar Tiwari
(Dr.) Amit Kumar Tiwari
The Theranostics approach has full potential to completely transform the contemporary medicine system to a patient-centric approach, as it is emerging in quite efficient manner, over the past few years. The primary impetus of this review is to analyse the patent growth in the domain of breast cancer theranostics. This wholesome analysis provides an insight into the current technological and R & D advancement over the years, in breast cancer theranostics. Thus, guide the end-users in getting the conclusion for policymaking and other public recommendations. This patent assessment also foretells about the future trends to carry out further achievements. Due to their easy availability, information richness, & versatility, patent's role in R&D policy has been emphasized by stake holders of innovation including scientists time to time. Graphical The figure illustrates the applied technologies used for breast cancer theranostics by top three forward cited patents (A) The oligonucleotides with specific sequences (comprised of at least one of DNA, RNA, PNA. LNA, UNA or combination)1 are capable of binding a targeted tumor protein (PARP1, HISTIHIB, HISTIHID, NCL, FBL, SFPQ, RPL12, ACTB, HIST1H4A, SSBP1, NONO, H2AFJ, and DDX21, forming a tumor protein complex or subunit or their fragments and might block the tumoral activity. These are also capable of binding to Ramos cells (Derived from Human Burkitt's lymphoma that is negative for Epstein Barr virus). These can also bind cell surface nucleolin and may inhibit cell proliferation. These molecules with detection agent detect the presence or level of disease specific protein. (B) These aptamers with chemical functionalization can be conjugated to an amine linker or high molecular weight non-immunogenic compound or a drug or cytotoxic moiety or labelled with fluorescent agent. These chemically modified aptamers can also bind disease - specific biomarkers e.g., circulating biomarkers, micro- vesicle surface antigens or their functional fragments and can be subsequently used for early diagnosis, prognosis or therapeutic purposes. 1PNA: Peptide Nucleic Acid. LNA: Locked Nucleic Acid. UNA: Unlocked Nucleic Acid.

19 February 2022 in Sustainable Water Resources Management
Verified
Journal Article
Closed access
PDF file
VPVandana Patyal
Vandana Patyal
DJDipika Jaspal
Dipika Jaspal
(Dr.) Amit Kumar Tiwari(Dr.) Amit Kumar Tiwari
(Dr.) Amit Kumar Tiwari
KKKanchan Khare
Kanchan Khare

4 April 2024 in Environmental Science and Pollution Research
Verified
Journal Article
Closed access
PDF file
SBSanjay B. Bhagwat
Sanjay B. Bhagwat
DJDipika Jaspal
Dipika Jaspal
(Dr.) Amit Kumar Tiwari(Dr.) Amit Kumar Tiwari
(Dr.) Amit Kumar Tiwari
AMArti Malviya
Arti Malviya
PPPetros Petrounias
Petros Petrounias

27 November 2021 in International Journal of Environmental Science and Technology
Verified
Journal Article
Closed access
PDF file
SDS. Dike
S. Dike
SASayali Deepak Apte
Sayali Deepak Apte
(Dr.) Amit Kumar Tiwari(Dr.) Amit Kumar Tiwari
(Dr.) Amit Kumar Tiwari

6 March 2010 in SSRN Electronic Journal
Verified
Preprint
Open access
PDF file
MRMamta Kumari Raturi
Mamta Kumari Raturi
PSPrabhat Kumar Sahoo
Prabhat Kumar Sahoo
SMSusmita Mukherjee
Susmita Mukherjee
(Dr.) Amit Kumar Tiwari(Dr.) Amit Kumar Tiwari
(Dr.) Amit Kumar Tiwari
Patinformatics is the application of informatics methods to provide the solution to the patent information and the analysis related problems. Although this term was introduced only a few years ago, but its applications can be in a wide range of scientific and business related fields. Method and techniques of different origins have now merged into one discipline that is full of interesting and informative activities. This paper primarily focuses on presenting a general overview of patinformatics and their application in business and various scientific fields including chemicals and pharmaceuticals with special reference to India. Although all the areas of science and technology can benefit from patinformatics methods, still there are many challenging patent information and analysis related problems waiting for solutions through further development of patinformatics.